Islam M Miligy (Islam Miligy)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Topics

Positive Breast Cancer

Top Venues

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

International journal of molecular sciences

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Islam M Miligy, Rachna Awasthi, Yasmeen Mir, Anuj Khurana, Vijay Sharma, Usha Chandaran, Emad Rakha, Yasmine Maurice, Daniel Kearns, Rami Oweis, Amal Asar, Alastair Ironside, Abeer M Shaaban
Morphological and molecular changes of oestrogen receptor-positive breast cancer following bridging endocrine therapy: a United Kingdom multicentre study. Histopathology 85 (3) (2024)
Islam M Miligy, Nahla Badr, Andrea Stevens, David Spooner, Rachna Awasthi, Yasmeen Mir, Anuj Khurana, Vijay Sharma, Usha Chandaran, Emad A Rakha, Yasmine Maurice, Daniel Kearns, Rami Oweis, Amal Asar, Alastair Ironside, Abeer M Shaaban
Pathological Changes Following Neoadjuvant Endocrine Therapy (NAET): A Multicentre Study of 391 Breast Cancers. International journal of molecular sciences 25 (13) (2024)
Islam M Miligy, Nahla Badr, Andrea Stevens, David Spooner, Rachna Awasthi, Yasmeen Mir, Anuj Khurana, Vijay Sharma, Usha Chandaran, Emad A Rakha, Yasmine Maurice, Daniel Kearns, Rami Oweis, Amal Asar, Alastair Ironside, Abeer M Shaaban
Pathological Changes Following Neoadjuvant Endocrine Therapy (NAET): A Multicentre Study of 391 Breast Cancers. International journal of molecular sciences 25 (13) (2024)
Islam M Miligy, Nahla Badr, Andrea Stevens, David Spooner, Rachna Awasthi, Yasmeen Mir, Anuj Khurana, Vijay Sharma, Usha Chandaran, Emad A Rakha, Yasmine Maurice, Daniel Kearns, Rami Oweis, Amal Asar, Alastair Ironside, Abeer M Shaaban
Pathological Changes Following Neoadjuvant Endocrine Therapy (NAET): A Multicentre Study of 391 Breast Cancers. International journal of molecular sciences 25 (13) (2024)
Islam M Miligy, Rachna Awasthi, Yasmeen Mir, Anuj Khurana, Vijay Sharma, Usha Chandaran, Emad Rakha, Yasmine Maurice, Daniel Kearns, Rami Oweis, Amal Asar, Alastair Ironside, Abeer M Shaaban
Morphological and molecular changes of oestrogen receptor-positive breast cancer following bridging endocrine therapy: a United Kingdom multicentre study. Histopathology (2024)
Asmaa Ibrahim, Michael S Toss, Shorouk Makhlouf, Islam M Miligy, Fayyaz Ul Amir Afsar Minhas, Emad A Rakha
Improving mitotic cell counting accuracy and efficiency using phosphohistone-H3 (PHH3) antibody counterstained with haematoxylin and eosin as part of breast cancer grading. Histopathology (2022)
Michael S Toss, Islam M Miligy, Kylie L Gorringe, Mohammed A Aleskandarany, Abdulbaqi Alkawaz, Karuna Mittal, Ritu Aneja, Ian O Ellis, Andrew R Green, Emad A Rakha
Collagen (XI) alpha-1 chain is an independent prognostic factor in breast ductal carcinoma in situ. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 32 (10) (2019)
Michael S Toss, Islam M Miligy, Kylie L Gorringe, Abdulbaqi AlKawaz, Karuna Mittal, Ritu Aneja, Ian O Ellis, Andrew R Green, Ioannis Roxanis, Emad A Rakha
Geometric characteristics of collagen have independent prognostic significance in breast ductal carcinoma in situ: an image analysis study. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 32 (10) (2019)
Islam M Miligy, Kylie L Gorringe, Michael S Toss, Abdulbaqi A Al-Kawaz, Peter Thomas Simpson, Maria Diez-Rodriguez, Christopher C Nolan, Ian O Ellis, Andrew R Green, Emad A Rakha
Thioredoxin-interacting protein is an independent risk stratifier for breast ductal carcinoma in situ. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 31 (12) (2018)
Reem Ali, Abdulbaqi Al-Kawaz, Michael S Toss, Andrew R Green, Islam M Miligy, Katia A Mesquita, Claire H Seedhouse, Sameer Mirza, Vimla Band, Emad A Rakha, Srinivasan Madhusudan
Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast Cancer or Preinvasive Ductal Carcinoma In Situ Induces Synthetic Lethality and Chemoprevention. Cancer research 78 (24) (2018)
Michael S Toss, Islam M Miligy, Kylie L Gorringe, L McCaffrey, Abdulbaqi AlKawaz, Asima Abidi, Ian O Ellis, Andrew R Green, Emad A Rakha
Legumain is an independent predictor for invasive recurrence in breast ductal carcinoma in situ. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 32 (5) (2018)
Islam M Miligy, Priya Mohan, Ahmed Gaber, Mohammed A Aleskandarany, Christopher C Nolan, Maria Diez-Rodriguez, Abhik Mukherjee, Caroline Chapman, Ian O Ellis, Andrew R Green, Emad A Rakha
Prognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ. Histopathology 71 (2) (2017)